|
Clinical Trials and Observations
Citations 301-310 of 2742 total displayed.
|
Past content
(since May 1998):
|
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
- Gregory A. Yanik, Vincent T. Ho, John E. Levine, Eric S. White, Thomas Braun, Joseph H. Antin, Joel Whitfield, Joseph Custer, Dawn Jones, James L. M. Ferrara, and Kenneth R. Cooke
Blood 2008; 112: 3073-3081.
[Abstract]
[Full text]
[PDF]
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
- Suzanne O. Arulogun, H. Miles Prince, Jonathan Ng, Stephen Lade, Gail F. Ryan, Odette Blewitt, and Christopher McCormack
Blood 2008; 112: 3082-3087.
[Abstract]
[Full text]
[PDF]
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
- Ken H. Young, Karen Leroy, Michael B. Møller, Gisele W. B. Colleoni, Margarita Sánchez-Beato, Fábio R. Kerbauy, Corinne Haioun, Jens C. Eickhoff, Allen H. Young, Philippe Gaulard, Miguel A. Piris, Terry D. Oberley, William M. Rehrauer, Brad S. Kahl, James S. Malter, Elias Campo, Jan Delabie, Randy D. Gascoyne, Andreas Rosenwald, Lisa Rimsza, James Huang, Rita M. Braziel, Elaine S. Jaffe, Wyndham H. Wilson, Louis M. Staudt, Julie M. Vose, Wing C. Chan, Dennis D. Weisenburger, and Timothy C. Greiner
Blood 2008; 112: 3088-3098.
[Abstract]
[Full text]
[PDF]
Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories
- Régis Peffault de Latour, Jean Yves Mary, Célia Salanoubat, Louis Terriou, Gabriel Etienne, Mohamad Mohty, Sophie Roth, Sophie de Guibert, Sebastien Maury, Jean Yves Cahn, and Gerard Socié, on behalf of the French Society of Hematology and of the French Association of Young Hematologists
Blood 2008; 112: 3099-3106.
[Abstract]
[Full text]
[PDF]
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
- Antonio Palumbo, Sara Bringhen, Anna M. Liberati, Tommaso Caravita, Antonietta Falcone, Vincenzo Callea, Marco Montanaro, Roberto Ria, Antonio Capaldi, Renato Zambello, Giulia Benevolo, Daniele Derudas, Fausto Dore, Federica Cavallo, Francesca Gay, Patrizia Falco, Giovannino Ciccone, Pellegrino Musto, Michele Cavo, and Mario Boccadoro
Blood 2008; 112: 3107-3114.
[Abstract]
[Full text]
[PDF]
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
- Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, Jeff Haessler, Elias Anaissie, Klaus Hollmig, Yazan Alsayed, Sarah Waheed, Nathan Petty, Joshua Epstein, John D. Shaughnessy, Jr, Guido Tricot, Maurizio Zangari, Jerome Zeldis, Sol Barer, and John Crowley
Blood 2008; 112: 3115-3121.
[Abstract]
[Full text]
[PDF]
Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease
- Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby, Mauricio Pineda-Roman, Klaus Hollmig, Yazan Alsayed, Antje Hoering, Jackie Szymonifka, Elias Anaissie, Nathan Petty, Naveen S. Kumar, Geetika Srivastava, Bonnie Jenkins, John Crowley, and Jerome B. Zeldis
Blood 2008; 112: 3122-3125.
[Abstract]
[Full text]
[PDF]
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
- Derville O'Shea, Ciarán O'Riain, Claire Taylor, Rachel Waters, Emanuela Carlotti, Finlay MacDougall, John Gribben, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Erlend B. Smeland, Nathalie Johnson, Elias Campo, Timothy C. Greiner, Wing C. Chan, Randy D. Gascoyne, George Wright, Louis M. Staudt, T. Andrew Lister, and Jude Fitzgibbon
Blood 2008; 112: 3126-3129.
[Abstract]
[Full text]
[PDF]
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- Miguel A. Sanz, Pau Montesinos, Edo Vellenga, Consuelo Rayón, Javier de la Serna, Ricardo Parody, Juan M. Bergua, Angel León, Silvia Negri, Marcos González, Concha Rivas, Jordi Esteve, Gustavo Milone, José D. González, Elena Amutio, Salut Brunet, J. García-Laraña, Dolors Colomer, María J. Calasanz, Carmen Chillón, Eva Barragán, Pascual Bolufer, and Bob Lowenberg
Blood 2008; 112: 3130-3134.
[Abstract]
[Full text]
[PDF]
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
- Alessandra Carobbio, Guido Finazzi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro M. Vannucchi, Federica Delaini, Vittoria Guerini, Marco Ruggeri, Francesco Rodeghiero, Alessandro Rambaldi, and Tiziano Barbui
Blood 2008; 112: 3135-3137.
[Abstract]
[Full text]
[PDF]
|
|
